Prometheus Laboratories Inc. obtains license to patent for pharmacogenetic test.
D000483:Alleles; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000493:pharmacokinetics; D001711:Biotransformation / Q000235:genetics; D004345:Drug Industry; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D008004:Licensure; D008780:Methyltransferases / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics*; D010330:Patents as Topic; D010597:Pharmacogenetics / Q000331:legislation & jurisprudence*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D008780:Methyltransferases; C022745:thiopurine methyltransferase